Elliot Shelton serves as Executive at Entia Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Elliot Shelton has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 14, 2017 involved receiving (via award) 250,000 shares valued at $0.
Elliot Shelton currently holds 976,250 shares of Entia Biosciences, Inc. (ERGO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Elliot Shelton has been a net neutral trader of ERGO stock. They have purchased $0 and sold $0 worth of shares.
Elliot Shelton's most recent insider trade was on Feb 14, 2017, when they sold 250,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 24, 2015 | ERGO | $40.0K | Award | 200,000 | $0.20 | Discretionary |